Nurix (NRIX) Stock Price Target Raised to $34 by H.C. Wainwright

H.C. Wainwright has raised its price target for Nurix Therapeutics (NRIX) to $34 per share. This revised target reflects an optimistic view on the company's potential growth and market opportunities. Nurix's stock may react positively as analysts adjust expectations based on recent developments. Investors should note that analysts' price targets can influence trading behavior and market sentiment.